Presentation
- 50 micrograms/mL ampoules
- 100 micrograms/mL ampoules
- 500 micrograms/mL ampoules
Keep Refrigerated
Role
Treatment of hypoglycaemia (BSL< 4.0 mmol/L) due to sulfonylurea overdose; following the initial correction with glucose. Commencing octreotide should prevent the need for an ongoing glucose infusion.
Dose
- 50 micrograms (child: 2 micrograms/kg) q8h SC for at least 24 hours.
- 50 micrograms (child: 2 micrograms/kg) IV load, followed by 25 micrograms/hour (child: 1microgram/kg/hour) infusion for at least 24hours.
Stocking recommendations
| Tertiary centre | Regional centre | Rural centre | Remote centre |
|---|---|---|---|
| Readily available for other indications | Readily available for other indications | Readily available for other indications | 0 ampoules |
Rationale
Octreotide is usually readily available in hospitals for other indications. Sufficient stock to treat a patient for at least 24 hours is recommended in rural centres.
Disclaimer
Fact sheet developed by Queensland Poisons Information Centre.
This fact sheet is about the use of these antidotes in Australia, and may not apply to other countries. Children’s Health Queensland Hospital and Health Service cannot be held responsible for the accuracy of information, omissions of information, or any actions that may be taken as a consequence of reading this fact sheet.